Fundraising FoxDelNova
Highland, US · Founded 2016 · 1 known investors
Find your way into DelNova
Sign up to see every warm intro you have to DelNova
- Paths you didn't know you had: your email and LinkedIn already hold routes to the DelNova team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing. Its work relates to injectable aesthetics such as neurotoxins and peripheral nerve applications.
Founders & leadership
DelNova was founded in 2016 by Mary Gardner.
MG
Mary GardnerCEO and FounderMary Gardner is the founder and CEO of DelNova, a life science company developing therapeutics in medical aesthetics and neuromuscular applications. She holds degrees from McMaster University and the University of Western Ontario and has extensive experience in pharmaceutical, biotechnology, and medical device sectors.
SB
Sameer B. ShahChief Scientist
SY
Steven YoelinChief Medical Strategist
DJ
Dimas JimenezChief Financial Advisor
Board
DB
Investors · 1
Reported raises · per SEC filings
Form D private placements$810.2K disclosed across 1 round · 2018
▶$810.2KraisedApr 2018 · 3 investors · OtherRule 506(b)
▶$810.2KraisedApr 2018 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Daniel BradburyDirector
- Mary GardnerExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $810.2K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
TeknovaTeknova develops reagents and custom buffer solutions for AAV (adeno-associated virus) downstream processing in gene therapy workflows. The company leverages 30 years of manufacturing expertise to address bottlenecks in AAV production for researchers and biotech organizations.
GrenovaGrenova develops laboratory technology for washing and reusing pipette tips and microwell plates, aimed at labs seeking to reduce consumable waste and costs. The company operates in the life sciences lab equipment and sustainability space.
Companies working in the same space as DelNova.
Frequently asked questions
- What does DelNova do?
- DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing. Its work relates to injectable aesthetics such as neurotoxins and peripheral nerve applications.
- Who founded DelNova?
- DelNova was founded by Mary Gardner in 2016.
- Who are DelNova's investors?
- DelNova's investors include BioBrit.
- How much funding has DelNova raised?
- DelNova has disclosed $810.2K raised across 1 round.
- Where is DelNova headquartered?
- DelNova is headquartered in Highland, US.